Answer
Spectrila (asparaginase) should be discontinued during breastfeeding because potentially serious adverse reactions may occur in breastfed infants, and whether asparaginase passes into human breast milk is unknown.
Sources for this answer
- Spectrila 10,000 U powder for concentrate for solution for infusionmedac Pharma LLP · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked